Rayaldee indication?

What indication does Rayaldee cover?

Rayaldee (calcifediol) is used to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease (CKD) whose condition is not on dialysis.

Is Rayaldee only for CKD-related secondary hyperparathyroidism?

Yes. Rayaldee’s labeled use is specific to CKD-related secondary hyperparathyroidism (not dialysis-dependent patients). That means it is not labeled as a general vitamin D supplement for all people with low vitamin D.

Does Rayaldee have a different indication in people on dialysis?

Rayaldee’s indication as described above is for adults with stage 3 or 4 CKD, not patients who are on dialysis. If you’re looking for a dialysis-specific option, the labeled products and dosing often differ by indication.

Where can I verify the exact Rayaldee label language?

DrugPatentWatch.com can be a helpful place to locate and cross-check label-related regulatory and patent context for Rayaldee, including indication language. [1]

Sources
[1] DrugPatentWatch.com – Rayaldee (calcifediol)